RecruitingPhase 3NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Sponsor: AstraZeneca
Inglewood, CA · Los Angeles, CA · Palo Alto, CA · +77 more sites
COPD clinical trials in Palo Alto, CA
2 recruiting copd studies with a site in Palo Alto, CA.
RecruitingPhase 1NCT06603246
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Sponsor: Genentech, Inc.
Palo Alto, CA · +6 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.